TREATMENT OF EOSINOPHIL OR MAST CELL RELATED DISORDERS

To provide methods for managing, treating, or preventing an eosinophil or mast cell related disorder and/or one or more symptoms thereof, for example a mast cell related disorder of the nervous system, e.g., central nervous system, for example neuromyelitis optica (NMO), neuromyelitis optica spectru...

Full description

Saved in:
Bibliographic Details
Main Authors GERALD MCMAHON, THERESA MARIE LAVALLEE
Format Patent
LanguageEnglish
Japanese
Published 21.01.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:To provide methods for managing, treating, or preventing an eosinophil or mast cell related disorder and/or one or more symptoms thereof, for example a mast cell related disorder of the nervous system, e.g., central nervous system, for example neuromyelitis optica (NMO), neuromyelitis optica spectrum disorder (NMOSD), multiple sclerosis (MS), and neurofibromatosis (NF).SOLUTION: The present invention provides a method including administering to a subject in need thereof a therapeutically effective amount of an antibody which specifically binds to a KIT receptor tyrosine kinase.SELECTED DRAWING: None 【課題】好酸球又はマスト細胞関連障害及び/又はその1以上の症状、例えば、神経系、例えば中枢神経系のマスト細胞関連障害、例えば視神経脊髄炎（ＮＭＯ）、視神経脊髄炎スペクトル障害（ＮＭＯＳＤ）、多発性硬化症（ＭＳ）、及び神経線維腫症（ＮＦ）を管理する、治療する、又は予防するための方法を提供する。【解決手段】治療有効量のＫＩＴ受容体型チロシンキナーゼに特異的に結合する抗体を、それを必要とする対象に投与することを含む方法である。【選択図】なし
Bibliography:Application Number: JP20200158560